The long-term term objective of this institutional NRSA is to train a new generation of pediatric subspecialists in basic scientific investigation. The general thematic focus of the NRSA training experience will be molecular medicine, defined as the use of sophisticated molecular approaches to improve diagnosis and treatment of pediatric diseases. The program will be physically located on the campus of Columbus Children's Hospital, the home of both Children's Research Institute (CRI) and the Department of Pediatrics (DOP/OSU) in the College of Medicine and Public Health, The Ohio State University. In the last few years, there has been a substantial resource commitment to research at CRI. Our long-range strategic plan includes a new 160,000 square foot research building contiguous with the extant Wexner Institute that will house 50 new state-of-the-art laboratory modules. The plan also calls for at least 40 new pediatric research scientists to be recruited by the end of 2006. To accommodate for this dramatic expansion, CRI has undergone a reorganization of its faculty and laboratories into Centers of Emphasis. These Centers purposefully dissolve the traditional academic division-based silos of research and provide for alignment of investigators based on scientific interests and needs. This unique organizational model allows the DOP/OSU to adopt a novel approach to subspecialty research training. In brief, each of the Centers will function as a training unit for fellows. The scientific training and mentoring for individual fellows will be the responsibility of the selected training unit (Center) and its faculty. Importantly, each Center will also stratify faculty based on training experience. Faculty with less training experience will be paired with an experienced mentor who will serve as a co-advisor. Using this approach, our goal is to not only provide outstanding training for the fellows, but also to """"""""train"""""""" junior faculty. This training model, combined with the organizational commitment to the research infrastructure, puts the DOP/OSU and Children's Hospital in position to offer a high-caliber subspecialty research training program for the first time in its 110-year history.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Institutional National Research Service Award (T32)
Project #
5T32HD043003-05
Application #
7229035
Study Section
Special Emphasis Panel (ZHD1-DSR-A (19))
Program Officer
Huang, Terry T-K
Project Start
2003-06-03
Project End
2008-04-30
Budget Start
2007-05-01
Budget End
2008-04-30
Support Year
5
Fiscal Year
2007
Total Cost
$99,082
Indirect Cost
Name
Nationwide Children's Hospital
Department
Type
DUNS #
147212963
City
Columbus
State
OH
Country
United States
Zip Code
43205
Honegger, Jonathan R; Tedesco, Dana; Kohout, Jennifer A et al. (2016) Influence of IFNL3 and HLA-DPB1 genotype on postpartum control of hepatitis C virus replication and T-cell recovery. Proc Natl Acad Sci U S A 113:10684-9
Robbins, Mary E; Dakhlallah, Duaa; Marsh, Clay B et al. (2016) Of mice and men: correlations between microRNA-17?92 cluster expression and promoter methylation in severe bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 311:L981-L984
Streby, Keri A; Shah, Nilay; Ranalli, Mark A et al. (2015) Nothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapy. Pediatr Blood Cancer 62:5-11
Al-Zaidy, Samiah; Rodino-Klapac, Louise; Mendell, Jerry R (2014) Gene therapy for muscular dystrophy: moving the field forward. Pediatr Neurol 51:607-18
Honegger, Jonathan R; Kim, Seungtaek; Price, Aryn A et al. (2013) Loss of immune escape mutations during persistent HCV infection in pregnancy enhances replication of vertically transmitted viruses. Nat Med 19:1529-33
Fuh, B; Sobo, M; Cen, L et al. (2009) LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model. Br J Cancer 100:106-12
Luce, Wendy A; Hoffman, Timothy M; Bauer, John Anthony (2007) Bench-to-bedside review: Developmental influences on the mechanisms, treatment and outcomes of cardiovascular dysfunction in neonatal versus adult sepsis. Crit Care 11:228
Caldas, Hugo; Fangusaro, Jason R; Boue, Daniel R et al. (2007) Dissecting the role of endothelial SURVIVIN DeltaEx3 in angiogenesis. Blood 109:1479-89
Fangusaro, Jason R; Caldas, Hugo; Jiang, Yuying et al. (2006) Survivin: an inhibitor of apoptosis in pediatric cancer. Pediatr Blood Cancer 47:4-13
Fangusaro, J R; Jiang, Y; Holloway, M P et al. (2005) Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome. Br J Cancer 92:359-65

Showing the most recent 10 out of 12 publications